LETTER: Britain's neglect of a vital science
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.From Professor A. T. Florence
Sir: Roger Dobson's article ("Try a little flower power", 23 May) on the pharmaceutical comeback of plants was timely. In spite of the long history of the derivation of medicinal agents from plants, interest in the pharmaceutical industry in screening plant extracts for biological activity and lead compounds, and the growing public interest in the safe use of herbal medicines, funding for this vital area of research has not been forthcoming in the UK.
Not here the "record levels of funding" that you cite elsewhere (" 'Foresight' fund to help appliance of science", 23 May). The Department of Pharmacognosy which was quoted in the article as being active in research into plants as sources of medicines is actually located in the School of Pharmacy of the University of London and is the last academic department with that title in the country. However the school, a top-rated research institution, has for the past two years received the lowest possible funding increase from the Higher Education Funding Council.
So the school is faced with the possibility that pharmacognosy will have to close, thus leaving the UK without an academic department devoted to the subject. This at a time of great potential and also at a time of great urgency, as the world's plant resource is being destroyed as the rainforests disappear. Research councils still seem more inclined to fund the activities of chemists who attempt to synthesise the often complex and challenging molecules that come from plants, rather than the primary quest for the isolation and identification of these drugs. It is time for change, or else Britain will once again lose out.
Yours sincerely,
A. T. FLORENCE
Dean
School of Pharmacy,
University of London
London, WC1
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments